Sir Richard Faull discusses a potential treatment breakthrough for Huntington's Disease on Brainstorming with Clare de Lore.

Over 90 percent of people with Huntington’s disease develop chorea. Learn about FDA-approved VMAT2 inhibitors, off-label ...

Latus Bio raised $42 million as it prepares to seek FDA approval to start a clinical trial for its gene therapy for ...

Families and researchers are advocating for Huntington's disease to be recognized as a rare disease in India to establish a ...

Huntington’s disease (HD), an inherited genetic disease that causes nerve cells in the brain to decay over time, needs to be ...

Gene-targeting therapies offer unprecedented hope for families facing this inherited brain disorder, but bureaucratic delays ...

Neuroscientists find two distinct cell populations in the striatum are affected differently by Huntington's disease. They believe neurodegeneration of one of these populations leads to motor ...

In the spring of 1872, a young physician in New York published a paper about “chorea,” a condition that caused people to lose their ability to speak, control movements, and behave. He noted that the ...

UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. People affected by Huntington’s disease could at last benefit from the ...